CASE PRESENTATION - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

CASE PRESENTATION

Description:

CASE PRESENTATION BY ... Born in CGH,born at 38 weeks gestation.Delivered by caesarian section for maternal cholestasis.No antenatal or postnatal concerns.No ... – PowerPoint PPT presentation

Number of Views:279
Avg rating:3.0/5.0
Slides: 25
Provided by: IM164
Category:

less

Transcript and Presenter's Notes

Title: CASE PRESENTATION


1
CASE PRESENTATION
  • BY DR K MOODLEY
  • SpR Paediatrics

2
CASE HISTORY
  • NAME- CT
  • DOB- 31/07/05
  • BIRTH HISTORY Born in CGH,born at 38 weeks
    gestation.Delivered by caesarian section for
    maternal cholestasis.No antenatal or postnatal
    concerns.No dysmorphic features noted at birth.

3
HISTORY -CONTINUED
  • Immunisations-up to date
  • SOCIAL HISTORY- Lives with her parents and older
    brother.No family history of metabolic bone
    disease.
  • DIETARY HISTORY-She was bottlefed on SMA gold
    since birth and was weaned at 4/12 of age.Diet
    has been mixed varied consisting of
    vegetables/pasta/cereals.

4
  • She had normal exposure to sunlight
  • DEVELOPMENT-
  • -Late crawling
  • -walked at 17 months of age
  • -Fine motor skills-nad
  • -Speech-nad
  • -vision and hearing-nad
  • -

5
EXAMINATION
  • AUXOLOGY
  • -Height -97.4cm(below expected mid parental
    height)
  • -Weight-16.5 kg

6
  • CHEST-clear
  • CVS-HS were normal,no murmurs heard
  • ABDOMEN- soft, non tender,with no palpable masses
  • CNS-nad

7
  • MUSCULOSKELETAL
  • -Bilateral bowed legs
  • -slight rickety rosary
  • -No frontal bossing
  • -No swollen joints noted

8
INVESTIGATIONS
  • Electrolytes nad
  • FBC nad
  • LFT-
  • ALT-13 Cor Ca-2.35 PTH-6.3
  • GGT-10 Phosp- 0.68
  • BILI-6 TP- 70
  • ALP-570 ALB-48
  • Ca-2.43 25(OH) vit D3- 35

9
URINE
CREATININE- 616
Ca- lt0.5
Cacreat ratio-lt0.82
Phosphcreat ratio-3.33
Total protein-0.02
Proteincreat ratio-32.5
Tubular reabsorption of phsosphate- low(lt60)
Urine organic acids- pending
Urine amino acids -negative
Urine glucose-negative
10
  • GENETIC TESTS
  • Negative for mutation in either PHEX gene or
    FGF23 gene.
  • Ongoing genetic tests to look for DMP1 gene.

11
  • RADIOLOGY
  • Xray of left wrist displayed degree of fraying
    and splaying at metaphysis ,consistent with
    rickets.
  • Subsequent xrays showed coarsened and trabecular
    appearance of bones consistent with a diagnosis
    of Hypophosphataemic rickets.

12
(No Transcript)
13
DIAGNOSIS

14
TREATMENT
  • Initially started on cholecalciferol 3000units
    daily for 3 months.
  • No improvement after correcting Vitamin D
    levels,subsequently started on alfacalcidiol
    500ng/day
  • Phosphate sandoz
  • Calcium-1-2 mmol/kg/day

15
  • HYPOPHOSPHATAEMIC RICKETS

16
PATHOPHYSIOLOGY
  • Mutation on PHEX 1 gene
  • Leads to loss of function mutation
  • FG23 acts on kidney to cause increased phosphate
    excretion and decreased alpha hydroxylase
    activity.
  • Phosphate wasting at level of proximal tubule
    which leads to inability to establish normal
    ossification.

17
CLINICAL SIGNS
  • Slowed growth rate in first year of life
  • Short stature
  • Reluctance to weightbear
  • Late dentition and multiple dental abscesses
  • Intellectual development is unaffected
  • Widened joint spaces and flaring and bowing at
    the knees

18
DIFFERENTIAL DIAGNOSES
  • Cystinosis
  • Fanconis syndrome
  • Tyrosinaemia
  • RTA
  • Hereditary hypophosphataemic rickets with
    hypocalcaemia
  • Vitamin D dependent rickets
  • Vitamin D deficient rickets

19
INVESTIGATIONS
  • Ca/Phosp/ALP
  • PTH
  • 25 OH vitaminD
  • Urinary loss of phosphate

20
  • Renal tubular phosphate reabsorption
  • Early morning urine should be used.
  • The TRP in X linked hypophosphataemic rickets is
    60
  • Repeated early measurement of ALP and renal
    phosphate handling allows early diagnosis in
    children

21
  • Tubular phosphate wasting in X linked
    hypophosphataemic rickets can be evident as early
    as 6 weeks,however there is very little evidence
    that early treatment in these patients improve
    outcome.

22
IMAGING
  • Radiography of wrists ,knees ,ankles and long
    bones
  • In children receiving treatment ,periodic renal
    ultrasound to monitor for the development of
    nephrocalcinosis

23
TREATMENT
  • Outpatient
  • Serial Ca and Phosphate measurements
  • Calcitriol
  • Alfacalcidiol
  • Calcium and phosphate supplements

24
  • Thank you
Write a Comment
User Comments (0)
About PowerShow.com